Evidence map›Paper›PMID 23130988›Full record

ArticleBMC public health2012

The Diabetes Pearl: Diabetes biobanking in The Netherlands.

Esther van't Riet, Miranda T Schram, Evertine J Abbink, Wanda M Admiraal, Marja W Dijk-Schaap, Frits Holleman, Giel Nijpels, Behiye Özcan, Hanno Pijl, Nicolaas C Schaper and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Characteristics associated with polypharmacy in people with type 2 diabetes: the Dutch Diabetes Pearl cohort.Diabetic medicine : a journal of the British Diabetic Association · 2021
    Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Biobanking: The Melding of Research with Clinical Care.Current genetic medicine reports · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 1 country.

Esther van't RietVU University Medical Center, EMGO Institute for Health and Care Research, Amsterdam, The Netherlands. e.vantriet@vumc.nl
Miranda T Schram
Evertine J Abbink
Wanda M Admiraal
Marja W Dijk-Schaap
Frits Holleman
Giel Nijpels
Behiye Özcan
Hanno Pijl
Nicolaas C Schaper
Eric J G Sijbrands
Bianca Silvius
Cees J Tack
Harold W de Valk
Bruce H R Wolffenbuttel
Coen D A Stehouwer
Jacqueline M Dekker
Maastricht University · NLAcademic Medical Center · NLEMGO Institute for Health and Care Research · NLErasmus MC · NLLeiden University Medical Center · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NLAmsterdam UMC Location VUmc · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes is associated with considerable comorbidity and severe complications, which reduce quality of life of the patients and require high levels of healthcare. The Diabetes Pearl is a large cohort of patients diagnosed with type 2 diabetes, covering different geographical areas in the Netherlands. The aim of the study is to create a research infrastructure that will allow the study of risk factors, including biomarkers and genetic determinants for severe diabetes complications. METHODS/

designBaseline examinations began November 2009 and will continue through 2012. By the end of 2012, it is expected that 7000 patients with type 2 diabetes will be included in the Diabetes Pearl cohort. To ensure quality of the data collected, standard operation procedures were developed and used in all 8 recruitment centers. From all patients who provide informed consent, the following information is collected: personal information, medication use, physical examination (antropometry, blood pressure, electrocardiography (ECG), retina photographs, ankle-brachial index, peripheral vibration perception), self-report questionnaire (socio-economic status, lifestyle, (family) history of disease, and psychosocial well-being), laboratory measurements (glucose, A1c, lipid profile, kidney function), biobank material (storage of urine and blood samples and isolated DNA). All gathered clinical data and biobank information is uploaded to a database for storage on a national level. Biobanks are maintained locally at all recruitment centers. DISCUSSION: The Diabetes Pearl is large-scale cohort of type 2 diabetes patients in the Netherlands aiming to study risk factors, including biomarkers and genetic markers, for disease deterioration and the development of severe diabetes complications. As a result of the well-designed research design and the national coverage, the Diabetes Pearl data can be of great value to national and international researchers with an interest in diabetes related research.

Indexed as

Biological Specimen BanksBiomedical ResearchCohort StudiesDiabetes Mellitus, Type 2HumansNetherlandsRisk Factors

Identifiers

PMID23130988
PMCPMC3527348
OpenAlexW2168294853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.